Eyesaline Eyewash Recall Issued Due to Microbial Contamination
Due to a potential risk of severe eye infections that may lead to vision loss, a recall has been issued for one lot of the emergency eye wash solution Eyesaline, which may be contaminated with Kiebsiella pneumoniae.
The Eyesaline Eyewash recall was announced by the FDA and Honeywell on August 19, after the potential contamination was discovered. Although no injuries or illnesses have been reported, Kiebsiella pneumoniae eye infections may pose a serious risk for users.
Eyesaline is a solution used for emergency eye rinsing after injury. The microbial contaminant that may be present in some bottles is commonly found in the mouth and on the skin, but can cause infections that might result in vision loss.
Did You Know?
Change Healthcare Data Breach Impacts Millions of Customers
A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.
Learn MoreThe recall affects about 9,700 32-ounce bottles of Eyesaline Eyewash Solution, sold through industrial sale distributors. It has a lot number of F16091-61, which can be found on the outside of the product case and on individual bottles.
Honeywell indicates that it has contacted all distributors who have received this lot, and they have been instructed to notify their customers.
The company has asked distributors to stop distributing the recalled eyewash solution and to return them to Honeywell for credit and replacement. The company has also asked commercial-industrial users to check whether their bottles are subject to the recall and to stop using the affected products and contact their distributor on how to have them replaced or how to receive credit.
Customers with questions have been asked to contact their distributor or Honeywell Customer Care at 1-800-430-5490. Anyone who experience any problems after using the recalled eyewash should contact their health care provider. Adverse reactions should be reported to the FDA’s MedWatch Adverse Event Reporting program.
0 Comments